Editorial: Give FDA post-approval oversight authority - washingtonpost.com

Editorial: Give FDA post-approval oversight authority - washingtonpost.com: ". . .the FDA should not be in the business of regulating by suspicion. It always must balance potential dangers against potential usefulness of a drug. . . . If anything, the episode makes the case for a bill that Sens. Edward M. Kennedy (D-Mass.) and Mike Enzi (R-Wyo.) recently shepherded through the Senate. . . . The legislation would give the FDA clear authority to order post-approval studies if the regulator got a whiff of undocumented risks."